Showing results (31-40 of 278) with videos related to
Sort By:
Pageof 28
Current Treatment Options in Cardiovascular Medicine|October 22, 2004
Neurohormonal Therapy for Congestive Heart FailureAllison M Pritchett, Douglas L MannJournal of Clinical Medicine|October 26, 2024
Thrombotic, Cardiovascular, and Microvascular Complications of Myeloproliferative Neoplasms and Clonal Hematopoiesis (CHIP): A Narrative ReviewAndrew I Schafer, Douglas L MannMethodist Debakey Cardiovascular Journal|August 26, 2024
The Pathobiology of Myocardial Recovery and Remission: From Animal Models to Clinical Observations in Heart Failure PatientsArick C Park, Douglas L MannArteriosclerosis, Thrombosis, and Vascular Biology|November 25, 2025
Cardio-Hematopoietic Axis in Cardiac Injury and Repair: From Adaptation to MaladaptationDouglas L Mann, Andrew I SchaferCurrent Heart Failure Reports|September 10, 2013
Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathiesMichael M Givertz, Douglas L MannClinical Investigation|October 25, 2014
Rethinking Phase II Clinical Trial Design in Heart FailureKory J Lavine, Douglas L MannCirculation|May 8, 2002
Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathwayDinesh Kalra, Natarajan Sivasubramanian, Douglas L MannCardiology Clinics|December 8, 2007
Anti-angiotensin therapy: new perspectivesKumudha Ramasubbu, Douglas L Mann, Anita DeswalTrends in Cardiovascular Medicine|January 15, 2004
The role of innate immune responses in the heart in health and diseasePascal Knuefermann, Jesus Vallejo, Douglas L MannHeart Failure Clinics|April 25, 2008
Spectrum of pleiotropic effects of statins in heart failureNitin Mathur, Kumudha Ramasubbu, Douglas L MannPageof 28